APA (7th ed.) Citation

G, A., & B, R. (2026). Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: A review of safety, efficacy, and potential disease modification. Leukemia & lymphoma, 67(7), 1492. https://doi.org/10.1080/10428194.2026.2666851

Chicago Style (17th ed.) Citation

G, Abu-Zeinah, and Reeves B. "Long-term Outcomes of Ropeginterferon Alfa-2b-njft in Polycythemia Vera: A Review of Safety, Efficacy, and Potential Disease Modification." Leukemia & Lymphoma 67, no. 7 (2026): 1492. https://doi.org/10.1080/10428194.2026.2666851.

MLA (9th ed.) Citation

G, Abu-Zeinah, and Reeves B. "Long-term Outcomes of Ropeginterferon Alfa-2b-njft in Polycythemia Vera: A Review of Safety, Efficacy, and Potential Disease Modification." Leukemia & Lymphoma, vol. 67, no. 7, 2026, p. 1492, https://doi.org/10.1080/10428194.2026.2666851.